Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor angiogenesis].

Andreas Bikfalvi1

  • 1Laboratoire des mécanismes moléculaires de l'angiogenèse, Inserm E0113, Université de Bordeaux I, avenue des Facultés, 33405 Talence. a.bikfalvi@angio.u-bordeaux1.fr

Bulletin Du Cancer
|November 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Versatile Microfluidic Extrusion-Based Hydrogel Platform for Self-Organization and Long-Term Maintenance of Engineered 3D Lymphatic Endothelium.

Advanced healthcare materials·2026
Same author

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

EMBO reports·2026
Same author

Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.

iScience·2025
Same author

A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas.

International journal of cancer·2025
Same author

Protocol for real-time measurement of mitochondrial bioenergetics in 3D-cultured brain tumor stem cells using the Resipher system.

STAR protocols·2025
Same author

Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile.

EMBO molecular medicine·2025
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
See all related articles

Tumor growth relies on angiogenesis, the formation of new blood vessels. Key pro-angiogenic and anti-angiogenic factors have been identified, revealing new therapeutic targets for cancer treatment.

Area of Science:

  • Oncology
  • Vascular Biology
  • Molecular Medicine

Context:

  • Tumor growth is critically dependent on angiogenesis, a process where new blood vessels form to supply tumors.
  • The 'angiogenic switch' is a prerequisite for tumor expansion, enabling nutrient and oxygen delivery.
  • Folkman's foundational work highlighted angiogenesis as a key step in tumor evolution.

Purpose:

  • To review the role of angiogenesis in tumor development.
  • To identify key molecular factors that stimulate or inhibit angiogenesis.
  • To explore the therapeutic potential of targeting angiogenic pathways in cancer.

Summary:

  • Angiogenesis, the formation of new blood vessels, is essential for tumor growth after the angiogenic switch.
  • Pro-angiogenic factors like vascular endothelial growth factor (VEGF) and fibroblastic growth factors (FGFs) promote vessel formation.

Related Experiment Videos

  • Anti-angiogenic factors such as angiostatin and platelet factor 4 (PF4) inhibit this process.
  • Understanding these molecular mechanisms is crucial for developing novel cancer therapies.

    • Impact:

    • The identification of specific pro- and anti-angiogenic molecules provides critical therapeutic targets.
    • Targeting angiogenesis offers a promising strategy for inhibiting tumor growth and progression.
    • This research underpins the development of anti-angiogenic therapies for various cancers.